Article Versions Notes

Shimada Y, Nakano M, Matsumoto A, Ozeki H, Abe K, Tajima Y, Yamai D, Nogami H, Nakano M, Tani T, et al. Discordance Between Radiological and Pathological Responses to Pembrolizumab in Mismatch Repair-Deficient Metastatic Colorectal Cancer: Implications for Precision Oncology. Cancers. 2025; 17(13):2233. https://doi.org/10.3390/cancers17132233

Shimada, Yoshifumi, Mae Nakano, Akio Matsumoto, Hikaru Ozeki, Kaoru Abe, Yosuke Tajima, Daisuke Yamai, Hitoshi Nogami, Masato Nakano, Tatsuo Tani, and et al. 2025. "Discordance Between Radiological and Pathological Responses to Pembrolizumab in Mismatch Repair-Deficient Metastatic Colorectal Cancer: Implications for Precision Oncology" Cancers 17, no. 13: 2233. https://doi.org/10.3390/cancers17132233

Shimada, Y., Nakano, M., Matsumoto, A., Ozeki, H., Abe, K., Tajima, Y., Yamai, D., Nogami, H., Nakano, M., Tani, T., Kawahara, M., Nishimura, A., Kobayashi, Y., Bamba, Y., Suzuki, S., Oyanagi, H., Ohashi, T., Kameyama, H., Iwaya, A., ... Wakai, T. (2025). Discordance Between Radiological and Pathological Responses to Pembrolizumab in Mismatch Repair-Deficient Metastatic Colorectal Cancer: Implications for Precision Oncology. Cancers, 17(13), 2233. https://doi.org/10.3390/cancers17132233